Scienture Holdings (SCNX) said Thursday that Suren Ajjarapu has stepped down as chief executive and chairman, with Dr. Shankar Hariharan and Dr. Narasimhan Mani taking over as co-CEOs.
Hariharan, named executive chairman, led Scienture before its 2024 merger with the current company, and Mani was appointed president and co-CEO after previously leading Scienture LLC, the company said.
Both executives were already leading the company's pharmaceutical unit and will continue in those positions, Scienture said.
Scienture also said Ajjarapu will remain an advisor to the board after overseeing the company's merger and exit from its healthcare IT platform.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。